Ying Chang

机构：Yanbian University of Science and Technology, Yanbian University, Wuhan University, Hubei Provincial Center for Disease Control and Prevention, Zhongnan Hospital of Wuhan University, Tianjin Central Hospital of Gynecology Obstetrics, Yanbian University Hospital · ORCID：0000-0001-8972-4109

发表论文 77 篇 · 总被引 4881 次 · h-index 29

代表论文

• Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma (2021 · Cancer Cell International · 被引 144)
• Protein lipidation in health and disease: molecular basis, physiological function and pathological implication (2024 · Signal Transduction and Targeted Therapy · 被引 93)
• MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation (2021 · Frontiers in Oncology · 被引 54)
• Inhibition of the lncRNA MIAT prevents podocyte injury and mitotic catastrophe in diabetic nephropathy (2022 · Molecular Therapy — Nucleic Acids · 被引 45)
• Association between gestational exposure and risk of congenital heart disease: A systematic review and meta-analysis (2021 · Environmental Research · 被引 39)
• RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4 (2023 · Oncogene · 被引 38)